- Home
- RCKT
as 12-18-2024 2:42pm EST
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 1.3B | IPO Year: | N/A |
| Target Price: | $52.40 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.75 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.58 - $32.53 | Next Earning Date: | 11-07-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 234928.88% |
Latest Rocket Pharmaceuticals Inc. News
RCKT Breaking Stock News: Dive into RCKT Ticker-Specific Updates for Smart Investing
MT Newswires
7 hours ago
Jefferies Initiates Coverage on Rocket Pharmaceuticals With Buy Rating, $29 Price Target
MT Newswires
7 days ago
Rocket Pharmaceuticals Prices Upsized $165 Million Stock Offering
Business Wire
7 days ago
Rocket Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
MT Newswires
8 days ago
Rocket Pharmaceuticals Plans $150 Million Public Offering of Common Shares
Business Wire
8 days ago
Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock
Business Wire
22 days ago
Rocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx Conference
Benzinga
a month ago
Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst
MT Newswires
a month ago
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday
Compare RCKT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RCKT Rocket Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.